文献速递头颈部肿瘤放疗放疗物理与技术

1.5 T MR-Linac上头颈部癌症扩散加权磁共振成像的可重复性

Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac.
PubMed 文献 · Radiother Oncol · 2022-07-25

本研究在1.5 T MR-Linac上评估头颈部癌症患者基于回波平面成像(EPI)的扩散加权磁共振成像(DW-MRI)所衍生表观扩散系数(ADC)的可重复性。11例患者在分次放疗期间每周至少进行一次测试/重测扫描,共分析81个数据集,结果显示各感兴趣区的重复性系数和组内相关系数,作者认为该ADC重复性看似合理,可用于未来生物自适应MR引导放疗。

要点

  • 11例头颈部癌症患者在1.5 T MR-Linac上完成测试/重测DW-MRI扫描,共分析81个数据集。
  • 左侧/右侧颌下腺平均测试ADC为1380/1416×10⁻⁶ mm²/s,重复性系数分别为271/281×10⁻⁶ mm²/s(相对19.4/21.8%)。
  • 腮腺、肿瘤大体体积和淋巴结的组内相关系数分别为0.97/0.94、0.75和0.83。

核心结论

  • 在1.5 T MR-Linac上基于EPI的DW-MRI所衍生的ADC,其重复性看似合理,可用于未来生物自适应MR引导放疗。

研究设计与样本

  • 共纳入11例头颈部癌症患者,在分次放疗期间每周至少进行一次测试/重测DW-MRI扫描,测试扫描于自适应MR引导放疗开始前采集,重测扫描于照射后采集。
  • EPI DW-MRI扫描b值为0、150、500 s/mm²,手动勾画腮腺、颌下腺、肿瘤大体体积和淋巴结的体积-of-interest,共分析81个数据集。

主要发现

  • 左侧/右侧颌下腺平均测试ADC值为1380/1416×10⁻⁶ mm²/s,腮腺为950/1010×10⁻⁶ mm²/s,肿瘤大体体积为1520×10⁻⁶ mm²/s,淋巴结为1344×10⁻⁶ mm²/s。
  • 左侧/右侧颌下腺重复性系数(相对重复性系数)为271/281×10⁻⁶ mm²/s(19.4/21.8%),腮腺为138/155×10⁻⁶ mm²/s(13.3/15.2%),肿瘤大体体积为457×10⁻⁶ mm²/s(31.3%),淋巴结为310×10⁻⁶ mm²/s(23.5%)。
  • 左侧/右侧颌下腺组内相关系数为0.80/0.87,腮腺为0.97/0.94,肿瘤大体体积为0.75,淋巴结为0.83。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Functional information acquired through diffusion-weighted magnetic resonance imaging (DW-MRI) may be beneficial for personalized head and neck cancer (HNC) radiotherapy. Technical validation is required before DW-MRI based radiotherapy interventions can be realized clinically. The aim of this study was to assess the repeatability of apparent diffusion coefficients (ADC) derived from DW-MRI in HNC using echo-planar imaging (EPI) on a 1.5 T MR-Linac. MATERIAL AND METHODS: A total of eleven HNC patients underwent test/retest DW-MRI scans at least once per week during fractionated radiotherapy at the MR-Linac. An EPI DW-MRI test scan (b = 0, 150, 500 s/mm2) was acquired before the start of adaptive MR-guided radiotherapy in addition to an identical retest scan after irradiation. Volumes-of-interest (VOI) were defined manually for parotid (PTs) and submandibular glands (SMs), gross tumor volume (GTV) and lymph nodes (LNs). Mean ADC was calculated for all VOI in all test/retest scans. Absolute/relative repeatability coefficients (RCs/relRCs) as well as intraclass correlation coefficients (ICCs) were determined for all VOIs. RESULTS: A total of 81 datasets were analyzed. Mean test ADC values were 1380/1416, 950/1010, 1520 and 1344 · 10-6 mm2/s for left/right SM and PT, GTV and LNs, respectively. Accordingly, RC (relRC) values were determined as 271/281 (19.4/21.8%) and 138/155 (13.3/15.2%), 457 (31.3%) and 310 · 10-6 mm2/s (23.5%). ICC resulted in 0.80/0.87, 0.97/0.94, 0.75 and 0.83 for left/right SM and PT, GTV and LNs, respectively. CONCLUSION: The repeatability of ADC derived from EPI DW-MRI at the 1.5 T MR-Linac appears reasonable to be used for future biologically adapted MR-guided radiotherapy.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Habrich J, Boeke S, Nachbar M, et al. Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac. Radiother Oncol. 2022. PMID: 35902042. doi:10.1016/j.radonc.2022.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。